394 related articles for article (PubMed ID: 17110073)
1. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
2. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
Vergne S; Bennetau-Pelissero C; Lamothe V; Chantre P; Potier M; Asselineau J; Perez P; Durand M; Moore N; Sauvant P
Br J Nutr; 2008 Feb; 99(2):333-44. PubMed ID: 17678570
[TBL] [Abstract][Full Text] [Related]
3. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
4. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet.
Larkin TA; Price WE; Astheimer LB
Nutrition; 2007 Oct; 23(10):709-18. PubMed ID: 17656069
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
6. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.
Törmälä RM; Appt S; Clarkson TB; Tikkanen MJ; Ylikorkala O; Mikkola TS
Climacteric; 2007 Dec; 10(6):471-9. PubMed ID: 18049940
[TBL] [Abstract][Full Text] [Related]
7. Absorption of isoflavones in humans: effects of food matrix and processing.
de Pascual-Teresa S; Hallund J; Talbot D; Schroot J; Williams CM; Bugel S; Cassidy A
J Nutr Biochem; 2006 Apr; 17(4):257-64. PubMed ID: 16109484
[TBL] [Abstract][Full Text] [Related]
8. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.
Allred CD; Twaddle NC; Allred KF; Goeppinger TS; Churchwell MI; Ju YH; Helferich WG; Doerge DR
J Agric Food Chem; 2005 Nov; 53(22):8542-50. PubMed ID: 16248551
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones.
Mathey J; Lamothe V; Coxam V; Potier M; Sauvant P; Bennetau-Pelissero C
J Pharm Biomed Anal; 2006 Jun; 41(3):957-65. PubMed ID: 16513315
[TBL] [Abstract][Full Text] [Related]
10. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
Hutchins AM; Slavin JL; Lampe JW
J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
12. Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids.
Maubach J; Depypere HT; Goeman J; Van der Eycken J; Heyerick A; Bracke ME; Blondeel P; De Keukeleire D
Obstet Gynecol; 2004 May; 103(5 Pt 1):892-8. PubMed ID: 15121562
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women.
Weickert MO; Reimann M; Otto B; Hall WL; Vafeiadou K; Hallund J; Ferrari M; Talbot D; Branca F; Bügel S; Williams CM; Zunft HJ; Koebnick C
J Negat Results Biomed; 2006 Aug; 5():11. PubMed ID: 16907966
[TBL] [Abstract][Full Text] [Related]
14. Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition.
Faughnan MS; Hawdon A; Ah-Singh E; Brown J; Millward DJ; Cassidy A
Br J Nutr; 2004 Apr; 91(4):567-74. PubMed ID: 15035683
[TBL] [Abstract][Full Text] [Related]
15. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.
Rowland IR; Wiseman H; Sanders TA; Adlercreutz H; Bowey EA
Nutr Cancer; 2000; 36(1):27-32. PubMed ID: 10798213
[TBL] [Abstract][Full Text] [Related]
16. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
[TBL] [Abstract][Full Text] [Related]
17. Review of the factors affecting bioavailability of soy isoflavones in humans.
Nielsen IL; Williamson G
Nutr Cancer; 2007; 57(1):1-10. PubMed ID: 17516857
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
Liu ZM; Ho SC; Woo J; Chen YM; Wong C
Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
[TBL] [Abstract][Full Text] [Related]
19. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
